Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.medidd.2020.100048 http://scihub22266oqcxt.onion/10.1016/j.medidd.2020.100048 32551437!7266598!32551437     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32551437.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Med+Drug+Discov 2020 ; 7 (ä): 100048 Nephropedia Template TP {{tp|p=32551437|t=2020. Can We Reduce Mortality of COVID-19 if We do Better in Glucose Control?|pdf=|usr=}}{{32551437}} gab.com Text Can We Reduce Mortality of COVID-19 if We do Better in Glucose Control JO: Med Drug Discov http://www.kidney.de/pget.php?&tw=1&pmid=32551437 #FOAvip The SARS-CoV-2 has infected more than 3 million people and caused more than 240,000 death globally. Among the COVID-19 patients, the prevalence of people with other chronic diseases, such as diabetes, high blood pressure, and coronary heart disease is much higher than others. More strikingly, the survival rate of diabetic patients is also much lower than in non-diabetic patients. In addition to the general damage of high glucose to cells and tissues, a recent discovery that high glucose activates interferon regulatory factor 15 promotes influenza virus -induced cytokine storm. This discovery may shed light on the high incidence of diabetes in COVID-19. Several diabetes prevention strategies together with recent significant data-driven diabetes prediction approaches, which may help COVID-19 treatments, have been proposed. Twit Text FOAVip Can We Reduce Mortality of COVID-19 if We do Better in Glucose Control ????Med Drug Discov http://www.kidney.de/pget.php?&tw=1&pmid=32551437 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32551437 #FOAvip English Wikipedia <ref>{{Cite pmid|32551437}}</ref> Can We Reduce Mortality of COVID-19 if We do Better in Glucose Control? #MMPMID32551437 Deng M; Jiang L; Ren Y; Liao J Med Drug Discov 2020[Sep]; 7 (ä): 100048 PMID32551437show ga The SARS-CoV-2 has infected more than 3 million people and caused more than 240,000 death globally. Among the COVID-19 patients, the prevalence of people with other chronic diseases, such as diabetes, high blood pressure, and coronary heart disease is much higher than others. More strikingly, the survival rate of diabetic patients is also much lower than in non-diabetic patients. In addition to the general damage of high glucose to cells and tissues, a recent discovery that high glucose activates interferon regulatory factor 15 promotes influenza virus -induced cytokine storm. This discovery may shed light on the high incidence of diabetes in COVID-19. Several diabetes prevention strategies together with recent significant data-driven diabetes prediction approaches, which may help COVID-19 treatments, have been proposed. äCan We Reduce Mortality of COVID-19 if We do Better in Glucose Control(epmc).pdf DeepDyve Pubget Overpricing